Navigation Links
Shingles Vaccine Associated With 55 Percent Reduced Risk of Disease
Date:1/11/2011

PASADENA, Calif., Jan. 11, 2011 /PRNewswire/ -- Receiving the herpes zoster vaccine was associated with a 55 percent reduced risk of developing shingles, according to a Kaiser Permanente study of 300,000 people that appears in the current issue of the Journal of the American Medical Association.

This retrospective study observed the outcomes of the effectiveness of the herpes zoster vaccine in a large, diverse population of men and women ages 60 years and older. Researchers found a significant reduced risk of shingles across all sub-groups -- those who are healthy as well as those with chronic conditions including diabetes or heart, lung or kidney diseases.

These study findings differ from the clinical trial of the vaccine, which observed its effectiveness on 38,000 participants 60 years of age and older and found it less effective for people older than 75. This new study found a 55 percent reduced risk of shingles among both adults 60 years and older, as well as adults 75 years and older who received the vaccine.

These findings support Centers for Disease Control and Prevention recommendations to offer the vaccine to eligible patients of all ages, including those over 75. Researchers note that additional examination of the vaccine's effect in the oldest group should continue. The herpes zoster vaccine was licensed in 2006, but uptake in the United States remains low: about 10 percent in 2009 in adults 60 years and older.

"Our study shows the vaccine has the potential to prevent tens of thousands of cases of shingles, a painful, lingering disease," said study lead author Hung Fu Tseng, PhD, MPH, a research scientist with the Kaiser Permanente Department of Research & Evaluation in Pasadena, Calif. "We suggest clinicians follow the CDC's recommendations to talk to their patients about the option of vaccination against this serious condition."

There are more than 1 million episodes of shingles every ye
'/>"/>

SOURCE Kaiser Permanente
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles.
2. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
3. Shingles Pain Treatment Will Benefit More Patients
4. June 2008 Mayo Clinic Womens HealthSource Highlights Shingles Vaccine for Pain Prevention, Tips to Avoid Antibiotic Resistant Infections, and Benefits of Broad Genetic Testing
5. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
6. Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer
7. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
8. Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older
9. Oklahoma City Thunder Point Guard Russell Westbrook and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health
10. NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial
11. Young Children In Developing World Receive Accelerated Access to Pfizers Prevenar 13 Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 24 de mayo de 2013  Volcano Corporation ... y fabricante de herramientas de precisión para terapia ... de la enfermedad vascular periférica y coronaria, anunció ... Ad enosine V asodilator I ndependent ... la sesión de ensayo clínico hot line late ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... 2013 Amgen (NASDAQ: AMGN ) will ... Conference on Thursday, May 30, 2013, at the Westin Boston ... a.m. Eastern Daylight Time. Arvind Sood , ... the conference. Live audio of the presentation can be accessed ... under Investors. A replay of the webcast will also be ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
(Date:5/23/2013)... FL (PRWEB) May 23, 2013 Onlinefitnessreview.com ... Belly Blast Diet to determine what makes this diet ... The published review highlights three main components of the ... achieving a positive mindset and the personal motivation that ... intake every 7 days to keep the metabolism rate ...
(Date:5/23/2013)... Vinci surgical robot maker Intuitive Surgical defeated negligent training ... according to Bloomberg.* The Rottenstein Law Group LLP, which ... disappointment in the ruling but encourages those looking to ... verdict as representative of all da Vinci lawsuits. , ... Surgical Inc.; 09-2-03136-5, Superior Court, Port Orchard, Wash.) focused ...
(Date:5/23/2013)... City, UT (PRWEB) May 23, 2013 ... , a comprehensive radiology learning environment for all ... prebuilt lessons and assessments, transforms the learning experience ... radiology curriculum. , “Until RADPrimer 3.0, ... second to none,” comments Dr. B.J. Manaster, Professor ...
(Date:5/23/2013)... , , THURSDAY, May 23 (HealthDay News) -- Glucosamine supplements ... and knee osteoarthritis may have an unexpected side effect: ... new study of older adults suggests. Glaucoma ... (IOP) or pressure inside the eye. Left untreated, glaucoma ... In the new study of 17 people, ...
(Date:5/23/2013)... May 23 (HealthDay News) -- A modified version ... fight brain tumors, preliminary research suggests. Scientists ... therapy, known as PVSRIPO, uses an engineered form ... cells, but attacks cancer cells. The therapy shows ... common and aggressive brain tumor, they said. ...
Breaking Medicine News(10 mins):Health News:Onlinefitnessreview.com Publishes 7 Day Belly Blast Diet Review 2Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:RADPrimer 3.0 Introduces Comprehensive Radiology Training Curriculum 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:Modified Polio Virus May Help Fight Brain Tumors, Study Suggests 2
... Warwick Medical School found that premature babies face a greater ... included 120,000 children born between 1983 and 2001. The findings ... and were born premature are more often placed on the ... were born before 34 weeks. The findings were penned down ...
... Siteman Cancer Center are a part of the new ... Medicine's Medical Photography, Illustration and Computer Graphics (MedPIC) department. ... and their families to paint a 4-inch square ceramic ... have been painted in this manner. These unique artworks ...
... for a appointment a local clinic now you can take ... 10 minutes//, ,Chlamydia is the most common sexually transmitted ... can be passed on to others without knowing. However, complications ... pregnancy and infertility in both men and women., ,The ...
... group jogging or jogging with a friend will be more ... ,Researchers led by Professor Elizabeth Gould at Harvard University compared ... exercise in a group and found that contrary to accepted ... reported online edition of Daily Mail. ,The researchers ...
... the kingdom was untouched by the avian flu disease. // ... of both the public and the government. He said that there ... , The minister made the remarks during a ... that occasion to celebrate this great achievement the people were served ...
... in the majority of the cases is caused by viral ... could be prevented by vaccination. // Cancer of cervix, liver, ... leukemia are thought to be caused by viruses. Stomach cancer ... Campaign said that viruses can trigger the disease in combination ...
Cached Medicine News:Health News:Home Chlamydia Test 2
... Stereo Cube is used to diagnose Stereo and ... use of polarized glasses. The test can ... stereopsis, visual attention, form and depth perception. The ... to 450 seconds of arc and is ideal ...
The Lang Stereotest was created to simplify stereopsis screening in children. It is based on two principles: random dots and cylindrical gratings. The Lang Stereotest I measures disparities: Star 600...
... test was developed to test for both crossed ... the more reliable red/green glasses to provide ... dependent on polarizing spectacles which can be quite ... attractive image of a butterfly which makes the ...
... to assist patients with red-green color deficiencies in ... off wavelengths shorter than 582 nm enabling an ... most difficult color distinctions. A color anomalous patient ... a color is in the longer or shorter ...
Medicine Products: